GCVRZ News Alert Sanofi-Aventis Cvr (GCVRZ) 0.75 12/13/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Sanofi-Aventis Cvr (GCVRZ) 0.75 $GCVRZ

Sanofi Rights - Is A $13 Payout Even Possible?
Anthony Cataldo - at Seeking Alpha - Wed Dec 10, 12:44PM CST

GCVRZ: 0.75 (unch)

Sanofi Rights Remain Overpriced And Drift Lower: The Market Is Efficient
Anthony Cataldo - at Seeking Alpha - Wed Dec 03, 6:31AM CST

GCVRZ: 0.75 (unch), SNY: 45.16 (-1.05)

Seven Fat Years Of Event-Driven Investing
Chris DeMuth Jr. - at Seeking Alpha - Mon Dec 01, 6:00AM CST

OSHC: 14.37 (-0.03), QLTI: 3.52 (-0.02), VRX: 138.71 (-0.18), GCVRZ: 0.75 (unch), COWN: 4.55 (-0.03), YHOO: 50.24 (+0.30), PFN: 10.10 (-0.20), LORL: 79.60 (-0.80), ARCC: 15.13 (-0.37), DTV: 83.47 (-0.43), ABBV: 65.27 (-1.76), GPT: 6.51 (+0.06), STRZA: 28.53 (-0.14), BABA: 105.11 (+0.14)

Wall Street Breakfast: Moody's Downgrades Japan's Sovereign Debt Rating
Wall Street Breakfast - Seeking Alpha - Mon Dec 01, 5:32AM CST
Outstanding Performance Article Rewards We're excited to announce our latest two Outstanding Performance award winners. Each author receives $2,500. Read more about our Outstanding Performance award winners here . Winner #1: Short idea on ...
AMX: 20.95 (-0.65), SNE: 20.33 (-0.41), WMT: 83.81 (-0.02), INTC: 36.22 (-0.48), GOOG: 518.66 (-9.68), VIV: 17.58 (-0.54), SPY: 200.89 (-3.30), TGT: 72.40 (-1.13), GOOGL: 521.51 (-10.60), FEYE: 29.12 (-0.32), OIBR: 0.43 (-0.01), AGCO: 42.16 (-0.76), GCVRZ: 0.75 (unch), LLY: 69.55 (-2.06), GSK: 42.42 (-0.93), PT: 1.31 (-0.05), TSU: 22.66 (-0.61), QQQ: 102.67 (-1.13), AZN: 71.80 (-1.80), TXN: 53.11 (-1.38)

Sanofi Rights - Is GCVRZ Underpriced Or Is The Market Efficient?
Anthony Cataldo - Seeking Alpha - Mon Dec 01, 5:31AM CST
Disclosure: The author remains long more than 20,000 shares of GCVRZ, but may sell and or trade this CVR. After purchasing 80,000 shares at an average cost of $0.315 less than 12 months ago, 60,000 shares were sold for $0.85 on November 28, 2014,...
GCVRZ: 0.75 (unch), SNY: 45.16 (-1.05)

Today In SA PRO: Wednesday, November 26
SA PRO Top Ideas - at Seeking Alpha - Thu Nov 27, 4:00AM CST
Top Idea: AGCO Corporation by Thomas Clark: Long / Mid-Cap / Farm & Construction Machinery / Value / Temporary Headwinds / Margin Expansion / Share Buyback / New Author / 40%+ Upside Top Idea: Sanofi-Aventis Value Right by Chris DeMuth,...
MAG: 37.55 (+0.42), AGCO: 42.16 (-0.76), GCVRZ: 0.75 (unch), ORAN: 16.64 (-0.45)

Best Idea For 2014: Sanofi Rights Post-FDA Approval
Chris DeMuth Jr. - at Seeking Alpha - Thu Nov 27, 4:00AM CST

BIIB: 344.49 (+2.16), PFE: 30.95 (-0.70), GCVRZ: 0.75 (unch), TEVA: 55.92 (-0.92), SNY: 45.16 (-1.05), NVS: 93.52 (-0.82)

CVRs on Lemtrada +135% following approval
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 6:19AM CST

GCVRZ: 0.75 (unch), SNY: 45.16 (-1.05)

Genzyme's Lemtrada approved by the FDA
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 8:47PM CST

GCVRZ: 0.75 (unch), SNY: 45.16 (-1.05)

One More Time: The Genzyme Contingent Value Right
Ruerd Heeg - Seeking Alpha - Wed Oct 29, 9:15AM CDT
The Genzyme Contingent Value Right (NASDAQ: GCVRZ ) is a bet on Genzyme's sales of MS drug Lemtrada, also called alemtuzumab. The drug is the most efficacious MS drug to date. It has some serious side effects which are remediable with proper...
BIIB: 344.49 (+2.16), GCVRZ: 0.75 (unch)

Market Maker Surveillance Report. BSX, SMA, EMC, BX, GCVRZ, PFMT, Bullishly Biased Price Friction For Thursday, September 11th 2014
M2 - Fri Sep 12, 4:16AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 4878 companies with "abnormal" market making, 2401 companies with positive Friction Factors and 2459 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bullish bias) in their stock prices. This means that there was more selling than buying in the stocks and their stock prices rose. Boston Scientific Corp (NYSE:BSX), Symmetry Medical Inc (NYSE:SMA), EMC Corp (NYSE:EMC), BIOX Corp (NYSE:BX), Sanofi SA (NASDAQ:GCVRZ), (NYSE FMT). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
BSX: 13.00 (+0.11), SMA: 9.27 (-0.04), BX: 32.91 (-0.94), PFMT: 6.19 (-0.09), GCVRZ: 0.75 (unch), EMC: 28.34 (-0.89)

Market Maker Surveillance Report. BAC, GE, MRVL, USB, WFC, GCVRZ, Bullishly Biased Price Friction For Thursday, September 4th 2014
M2 - Fri Sep 05, 3:10AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 4751 companies with "abnormal" market making, 1909 companies with positive Friction Factors and 3133 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bullish bias) in their stock prices. This means that there was more selling than buying in the stocks and their stock prices rose. BANK OF AMERICA CORPORATION (NYSE:BAC), General Electric Co (NYSE:GE), Marvell Technology Group Ltd (NASDAQ:MRVL), U.S. Bancorp (NYSE:USB), WELLS FARGO & COMPANY (NYSE:WFC), Sanofi SA (NASDAQ:GCVRZ). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
GE: 24.89 (-0.52), USB: 43.89 (-0.81), MRVL: 14.19 (-0.21), GCVRZ: 0.75 (unch), WFC: 53.70 (-0.73), BAC: 17.13 (-0.34)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bacterial Breakthrough in Cancer Therapy: Game Changer?

Updated Category News Views 35

Blurring Lines Between Bugs and Biotech Well, wouldn't you know it, the eggheads over at Jeonbuk National University in South Korea are at it again, pushing the boundaries of what these little bacterial buggers can do. This time, they’ve had a crack at cancer therapy, using engineered Salmonella to pack a double punch against breast cancer in mice. Now, if that ain't...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 234

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 147

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Medtronic's Bold Move to Own Carotid Market Full-Scale

Updated Category News Views 143

When a giant like Medtronic makes a move, you can bet investors take notice, and this latest acquisition is no exception. They’re reaching into their deep pockets to acquire Contego Medical, a company shaking up the world of carotid artery disease treatments. It’s a tactical strike to solidify their leadership in cardiovascular solutions. Medtronic's Bet on Innovation...

Continue Reading
Webull Faces FINRA Fine and Legal Battle Ahead

Updated Category News Views 45

Webull's Compliance Headache Webull’s been knocked around again. This time, the Financial Industry Regulatory Authority (FINRA) slapped it with a hefty $4.2 million fine. Talk about a hit to the wallet! It all boils down to them failing to roll out some basic anti-money laundering (AML) and other crucial compliance programs. This is no small oversight, and it's got...

Continue Reading
Gwen Stefani Kicks Off OCVIBE's New Concert Hall

Updated Category News Views 116

A Homecoming Steeped in Nostalgia Orange County’s about to do a serious throwback, folks! Gwen Stefani is set to headline the opening concert at OCVIBE's spanking new concert hall in Anaheim on March 17, 2027. Curious choice for their opener? Hardly. This gal's practically woven into the county’s tapestry—her roots run deep here, enough to make even the casual music...

Continue Reading
Mining Equipment Market to Surge, Hitting $42.81B by 2033

Updated Category News Views 98

Forecasts on Market Growth: A Robust Climb Ahead Brace yourself because this mining equipment racket is ramping up like you wouldn't believe. Analysts are telling us the market's supposed to roar from a $28.42 billion check in 2026 to a jaw-dropping $42.81 billion come 2033. That's a 6.0% CAGR—a figure that'll catch the eye of anyone not sound asleep at the wheel....

Continue Reading
WHP Global's Japan Move: A Major Toy Market Play

Updated Category News Views 35

New Horizons for Toys"R"Us in Japan Well, folks, look who's back in the toy game with a vengeance! WHP Global is shaking hands with Pan Pacific International Holdings (PPIH) to breathe new life into Toys"R"Us across Japan. Now PPIH isn’t just any player. We're talking about Japan's fourth-largest retailer, helming giants like Don Quijote and aiming to crown itself as...

Continue Reading
Lear Gears Up for Goldman Sachs Event Spotlight

Updated Category News Views 10

Lear Prepares for the Big Stage in London Autumn leaves and industry insights are falling in full swing as Lear Corporation gets its ducks in a row for the upcoming Goldman Sachs 18th Annual Industrials & Autos Week. Kicking off on December 3, 2026, this gathering in London isn't just another checkbox on their corporate calendar—it's a prime moment in the spotlight....

Continue Reading
Ballard's Q3 2026: Navigating Losses and Bold Moves

Updated Category News Views 80

Ballard’s Financial Puzzles in Q3 2026 Riding the rough waters of the third quarter in 2026, Ballard Power Systems set out its stall with some eyebrow-raising numbers. This ain't the bustling diner vibe we normally see for a thriving business. The results paint a cautious picture sprinkled with strategic shifts that demand a keen eye. GeoPura Acquisition: A Strategic...

Continue Reading

Top 5 Most Recently Viewed Articles

U.S. Industrial Production Unexpectedly Declines, Impacting Growth

Updated Category News Views 62

U.S. Industrial Production Experiences a Notable Decline The latest report reveals that U.S. industrial production has faced an unexpected decline, recorded at -0.3%. This drop highlights the ongoing struggles within the manufacturing, mining, and utility sectors. Disappointing Performance Against Expectations When comparing the -0.3% figure to a predicted decrease of...

Continue Reading
MAXHUB Partners with Microsoft to Enhance Teams Rooms Experience

Updated Category News Views 363

MAXHUB Collaborates with Microsoft to Enhance Teams In an exciting development within the tech landscape, MAXHUB is teaming up with Microsoft in an initiative aimed at improving the security and reliability of Microsoft Teams Rooms. This partnership aligns with MAXHUB's vision of leading in integrated commercial display and unified communications solutions, providing...

Continue Reading
US Dollar Strengthens While Global Markets Face Turmoil

Updated Category News Views 486

US Dollar's Rise Amid Trade Tensions In an unexpected turn of events, the US dollar has extended its gains following President Trump's announcement of new tariffs. As the global markets react to these developments, we dive into the implications for various economies and asset classes. The latest updates indicate that the 25% tariffs on imports from Canada and Mexico,...

Continue Reading
Understanding Your Rights as a Perrigo Company Shareholder

Updated Category News Views 135

Understanding Your Rights as a Perrigo Company Shareholder Shareholders of Perrigo Company plc (NYSE: PRGO) should stay informed about recent developments regarding potential securities law violations. The underlying issues stem from allegations that the company misled investors regarding its infant formula business, which has drawn significant scrutiny. Allegations...

Continue Reading
Spring Surprises: White Castle Unveils Exciting Deals Ahead

Updated Category News Views 521

Spring Promotions at White Castle As the season transforms, White Castle, the pioneering fast-food restaurant known for its Original Slider, unveils enticing deals for its loyal customers. Embracing longer days and warmer weather, the company is determined to deliver exceptional savings for all cravings this spring. Celebrating with Value-Driven Offers White Castle is...

Continue Reading